Metraipolis › archive › dc_3bcfc3e64079

Genomic alterations and dynamic molecular residual disease monitoring predict pathological response to neoadjuvant chemoimmunotherapy in esophageal squamous… — Europe PMC PMID:42148099

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42148099
DOI
10.3389/fimmu.2026.1681959
License (as archived)
solo-consultazione
Archived
2026-11-02T21:04:41.260Z
SHA-256 of the archived text
b75bb033e203a0b977203eae66a2ab779805ad604ddce8a8cae0112e31edc7e9
Stable URL of this page
https://metraipolis.com/documento/dc_3bcfc3e64079

How to cite

Genomic alterations and dynamic molecular residual disease monitoring predict pathological response to neoadjuvant chemoimmunotherapy in esophageal squamous… — Europe PMC PMID:42148099 — Europe PMC (en), https://europepmc.org/article/MED/42148099 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3bcfc3e64079 (Metraipolis archive dc_3bcfc3e64079, sha256 b75bb033e203a0b977203eae66a2ab779805ad604ddce8a8cae0112e31edc7e9)
BibTeX
@misc{dc3bcfc3e64079,
  title = {Genomic alterations and dynamic molecular residual disease monitoring predict pathological response to neoadjuvant chemoimmunotherapy in esophageal squamous… — Europe PMC PMID:42148099},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148099},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3bcfc3e64079; sha256 b75bb033e203a0b977203eae66a2ab779805ad604ddce8a8cae0112e31edc7e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148099. Agents can read the archived copy with the MCP tool read_document.